About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Wednesday, March 9th, 2016

The QualityStocks
Daily Stock List


Daybreak Oil and Gas, Inc. (DBRM)

SmallCapVoice, The Green Baron, and Goldman Small Cap Research reported earlier on Daybreak Oil and Gas, Inc. (DBRM), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Daybreak Oil and Gas, Inc. is an independent oil and gas enterprise engaged in the exploration, development, and production of oil and natural gas in California and Kentucky. Its fundamental business model is finding and developing shallow oil and gas reserves by way of exploration and development activities, and selling the production from those reserves at a profit. Daybreak Oil and Gas is based in Spokane Valley, Washington.  In addition, it has an operations office in Friendswood, Texas. 

The Company owns a 3-D seismic survey, which consists of 20,000 acres over 32 square miles with around 6,500 acres under lease in the San Joaquin Valley of California. Daybreak Oil and Gas operates production from 20 wells in its East Slopes project area in Kern County, California. Furthermore, Daybreak owns a 25 percent working interest (WI) in approximately 7,300 acres under lease in the Appalachian Basin in Lawrence County, Kentucky. Here, it is presently participating in an ongoing oil well development program with 13 producing wells at the Twin Bottoms field.

Regarding the Company’s California drilling plans, future drilling plans include a combination of exploratory drilling and development well drilling. Daybreak states that planned drilling activity and the implementation of its full development plan will not begin until there is a sustained improvement in crude oil prices and additional financing is put in place.

The Company announced in January of 2015 that the Jackson H-20 oil well at the Twin Bottoms Field in Lawrence County, Kentucky was put on production January 20, 2015.  The initial flow rate from the Jackson H-20 well was roughly 520 barrels of oil per day. 

Additionally, in April of 2015, Daybreak Oil and Gas announced that its fully-engineered proved oil reserves grew by 18 percent to 888,136 Barrels of Oil Equivalent (BOE) for the fiscal year ended February 28, 2015.  Daybreak’s proved reserves at February 28, 2014 were 750,165 BOE.

In this current fiscal year, Daybreak Oil and Gas said that it will continue to look for additional financing for its planned exploration and development activities in Kentucky and California. Daybreak has engaged an investment banking firm to help in securing refinancing of its debt under more favorable terms and implement its development plans in California and Kentucky.

Daybreak Oil and Gas, Inc. (DBRM), closed Wednesday's trading session at $0.028, up 40.70%, on 34,304 volume with 5 trades. The average volume for the last 60 days is 50,601 and the stock's 52-week low/high is $0.01/$0.10.

U.S. Stem Cell, Inc. (USRM)

We are highlighting U.S. Stem Cell, Inc. (USRM) today, here at the QualityStocks Daily Newsletter.

U.S. Stem Cell, Inc. is an emerging company in the regenerative medicine/cellular therapy industry. It is a developer of novel autologous cell therapies, and a provider of physician based stem cell therapies to human and animal patients. Formed in 1999, U.S. Stem Cell is headquartered in Sunrise, Florida. The Company’s shares trade on the OTC Markets’ OTCQB.

The Company formerly went by the name Bioheart, Inc. It changed its corporate name to U.S. Stem Cell, Inc. in October of 2015. The Company’s concentration is on the discovery, development and commercialization of cell based therapeutics that prevent, treat or cure disease through repairing and replacing damaged or aged tissue, cells and organs and restoring their normal function.

U.S. Stem Cell has three operating divisions. These are: US Stem Cell Training, Vetbiologics, and US Stem Cell Clinic. The Company’s business include the development of proprietary cell therapy products and revenue generating physician and patient based regenerative medicine/cell therapy training services, cell collection and cell storage services, the sale of cell collection and treatment kits for humans and animals, and also the operation of a cell therapy clinic.

U.S. Stem Cell announced this past December that it successfully completed five physician based treatments of traumatic brain injury (TBI) patients. The five patients, who received stromal vascular fraction from adipose tissue delivered intrathecally, were treated over the past 12 months at the U.S. Stem Cell Clinic in Sunrise, Florida.

U.S. Stem Cell also announced this past December the completion of its name change with its new trading symbol - USRM. Additionally, it completed a financing transaction with Magna Equities II, LLC.

Last month, the Chief Science Officer of US Stem Cell, Kristin Comella, and a team of researchers from Florida International University and Mississippi State University published a paper in Plos One Journal. The team investigated the effectiveness of integrating tissue engineered cartilage derived from human bone marrow derived stem cells (HBMSCs) to healthy and also osteoarthritic cartilage mimics utilizing hydroxyapatite (HA) nanoparticles immersed within a hydrogel substrate. Assessment of explanted rabbit knees by histology demonstrated that cellularity within the repair tissues that had filled the defects were of considerably higher number.

U.S. Stem Cell, Inc. (USRM), closed Wednesday's trading session at $0.2998, up 19.92%, on 90,491 volume with 11 trades. The average volume for the last 60 days is 25,879 and the stock's 52-week low/high is $0.19/$10.90.

TSS, Inc. (TSSI)

RedChip and Wall Street Resources reported previously on TSS, Inc. (TSSI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed TSS, Inc. is a data center and mission critical facilities and technology services enterprise. The Company is a single source provider of mission-critical planning, design, system integration, deployment, maintenance and development of data centers facilities and information infrastructure. Founded in 2004, the Company previously went by the name Fortress International Group, Inc. It changed its name to TSS, Inc. in June of 2013. TSS has its corporate office in Round Rock Texas.

The Company provides a single-source solution for mission-critical facilities, including data centers, operations centers, network facilities, server rooms, security operations centers, communications facilities, and the infrastructure systems.

TSS specializes in customizable end to end solutions powered by industry experts and inventive services. These include technology consulting, engineering, design, project management, operations, facilities management, technology system installation and integration, and maintenance for traditional and modular data centers.

Last month, TSS provided preliminary results for its Q4 and fiscal year ended December 31, 2015. Q4 highlights include revenue of roughly $10 million versus $8.4 million in Q4 of 2014 and $6.3 million in Q3 of 2015. The Company realized gross margin of approximately 25 percent in Q4 of 2015 versus 31 percent in Q4 of 2014. TSS reduced operating expenses by 10 percent versus Q4 of 2014.

In addition, the Company realized Adjusted EBITDA income of approximately $400,000 versus Adjusted EBITDA income of $201,000 in Q4 of 2014 and an Adjusted EBITDA loss of $93,000 in Q3 of 2015.

Regarding TSS’ fiscal year highlights, it achieved 2015 revenue of around $29 million versus $28 million in 2014. It achieved gross margin of 28 percent in 2015 and 31 percent in 2014. The Company reduced operating expenses by roughly 7 percent versus 2014. It had an Adjusted EBITDA loss of approximately $0.8 million versus an Adjusted EBITDA loss of $1.5 million in 2014.

TSS, Inc. (TSSI), closed Wednesday's trading session at $0.10, up 231.13%, on 305 volume with 2 trades. The average volume for the last 60 days is 4,934 and the stock's 52-week low/high is $0.02/$0.75.

Pegasi Energy Resources Corp. (PGSI)

PennyPickAlerts and Fortune Stock Alerts reported this month on Pegasi Energy Resources Corp. (PGSI), AwesomePennyPicks and FeedBlitz did previously, and today we report on the Company as well, here at the QualityStocks Daily Newsletter.

Tyler, Texas based Pegasi Energy Resources Corp. is an independent energy company listed on the OTC Markets’ Group’s OTCQB. The Company engages in the exploration, development and production of oil and natural gas. Its operations are exclusively centered on the development of resources in the long established Rodessa oil field of East Texas. This is where Pegasi Energy Resources holds interests in properties in Marion and Cass counties. The Rodessa oil field has been producing oil and gas since 1929. Most of the Rodessa’s wells were drilled more than 50 years ago and targeted the shallower horizons.

Pegasi Energy Resources is the successor entity to First Southern Crown Ltd., a Texas limited partnership established in December of 2002 as a holding company for several operating subsidiaries. Before the formation of First Southern Crown, Pegasi’s principals spent more than three years and invested in excess of $3.5 million in developing a proprietary database, evaluating title and acreage acquisition in the Rodessa oil field.

These assets were assigned to First Southern Crown by TR Energy, Inc.  In March of 2007, Pegasi Energy Resources was created as a Texas corporation. In addition, First Southern Crown changed its name to Pegasi Energy Resources Corp. and converted into that Texas corporation as part of a consolidation and corporate restructuring.

Pegasi’s business strategy is to apply the latest horizontal drilling and fracture stimulation techniques to develop the deeper relatively underdeveloped reservoirs, which were overlooked by prior developers who did not have the relevant technology.

The Rodessa oil field has so far produced greater than 400 million barrels of oil and 2.3 trillion cubic feet of gas from more than 2,000 producing wells. This production has come from multiple formations including the Rodessa, Travis Peak, Pettit, Cotton Valley and Bossier - all proven reservoirs. Pegasi Energy Resources has established a leading acreage position in the Rodessa oil field. The Company owns in excess of 40 miles of pipeline infrastructure to transport its production to market.

Pegasi Energy Resources Corp. (PGSI), closed Wednesday's trading session at $0.0238, up 8.68%, on 242,531 volume with 21 trades. The average volume for the last 60 days is 24,213 and the stock's 52-week low/high is $0.006/$0.25.

Concierge Technologies, Inc. (CNCG)

TopPennyStockMovers, Pumps and Dumps, Epic Stock Picks, EpicVIP Group, MomentumOTC, and PennyStocks24 reported earlier on Concierge Technologies, Inc. (CNCG), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, Concierge Technologies, Inc. operates via its wholly-owned subsidiary company Kahnalytics, Inc. Furthermore, the Company entered into an agreement to acquire Gourmet Foods. Ltd. of Tauranga, New Zealand. The acquisition of Gourmet Foods, Ltd. completed on August 11, 2015. Concierge Technologies has its corporate headquarters in Valley Center, California.

Kahnalytics provides installation and technical support services to a considerable number of insured commercial fleets throughout America. At present, it offers the hardy, dual-lens, Janus V2 high definition camera with integrated GPS tracking and Wi-Fi connectivity. Kahnalytics purchases hardware, such as cameras and SD Cards, for configuration before release to end users.

Concerning Gourmet Foods (established in 1966), it is a well-established producer of popular New Zealand meat pies and bakery products under recognized supermarket brand names “Pat’s Pantry” and “Ponsonby Pies”. Gourmet Foods products are in convenience stores, major supermarkets, petrol stations and restaurants. Currently, Gourmet Foods employs approximately 45 persons. It distributes greater than 30 products across New Zealand generating more than 60,000 pieces weekly and growing.

In January 2016, Concierge Technologies announced the completion of its enhanced production line facilities. It had advanced a loan of NZ$250,000 to Gourmet Foods reserved for acquisition of a high capacity packaging machine to accommodate expected production increases because of greater sales of its family-sized products to national grocery chains. The new machinery is now installed. Moreover, the Company said that production is running smoothly. Sales have increased for the family-sized product by as much as 66 percent over preceding demands for comparison periods.

In addition, this past January, Concierge Technologies announced that it completed the transition from the "pink sheets" to the OTC Market Group QB exchange.

Mr. David Neibert, Concierge Technologies’ Chief Financial Officer, said "We are pleased to have made this transition to the next level of the OTC Markets exchange. By moving up to the QB designation we open more opportunities to our investors and shareholders to trade in our shares through brokerage firms who no longer trade "pink sheet" status securities.”

Concierge Technologies, Inc. (CNCG), closed Wednesday's trading session at $0.037, even for the day, on 15,100 volume with 3 trades. The average volume for the last 60 days is 5,512 and the stock's 52-week low/high is $0.01/$0.12.


The QualityStocks
Company Corner


Alternet Systems, Inc. (ALYI)

The QualityStocks Daily Newsletter would like to spotlight Alternet Systems, Inc. (ALYI). Today, Alternet Systems, Inc. closed trading at $0.015, up 111.27%, on 368,810 volume with 34 trades. The stock’s average daily volume over the past 60 days is 50,517, and its 52-week low/high is $0.0055/$0.045.

Alternet Systems, Inc. (ALYI) invests in and partners with companies that are creating the future of money in the high growth, emerging technology fields of digital commerce, multichannel payments, and predictive analytics.

Vision: Be the leading digital commerce, multichannel payments, predictive analytics solutions provider into global markets

Mission: To provide innovative solutions that facilitates and expedites commerce, enriching our partners and their customers' experience, and improving efficiency. Recognizing that the world is becoming increasingly dependent on technological conveniences, Alternet Systems aims to provide its customers with the tools to prepare themselves for a new era of digital commerce and payments, financial services and consumer information, and, most importantly, a new era of how to live.

Since 2010, Alternet has maintained a progressive focus on the high-growth, mobile value-added service industries of mobile financial services and mobile security. In 2014, the company expanded its scope of expertise to include in its investment verticals the exciting digital commerce space, transforming the legacy electronic payments infrastructure and developing advanced predictive data analytics applications for the mass consumer, telecommunications and financial industry.

With strategic investments in these three key, high-growth markets, Alternet is accelerating the future of money and its role in the global demand for these services. The company is guided by a team of executives specializing in entrepreneurial endeavors, innovation, corporate strategy, financial and executive management of multi-national organizations, and a vast network of industry resources.

As Alternet embarks on this new path, the company will be led by a management team and board of directors with over a century's worth of combined experience in the fields of investing, technology, and financing, and the consensus knowledge of where to invest and when in start-up and early-stage companies. Disclaimer

Alternet Systems, Inc. Company Blog

Alternet Systems, Inc. News:

Alternet Systems Announces Caprock Research Report with Near Term Price Target of $0.05 and 'Accumulate' Recommendation

Alternet Systems Launches Data Analytics Division To Build On Existing Revenue Base

Alternet Systems (ALYI) CEO Featured in Exclusive QualityStocks Interview

International Stem Cell Corp. (ISCO)

The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $3.96, up 3.12%, on 18,947 volume with 51 trades. The stock’s average daily volume over the past 60 days is 9,132, and its 52-week low/high is $1.25/$11.625.

International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human stem cells and the development and commercialization of cell-based biomedical products. The company was the first to develop and perfect a new class of human stem cells called parthenogenetic stem cells, created from unfertilized human eggs. ISCO has a strong patent portfolio offering clean intellectual property and freedom to operate. The company’s stem cells present superior immune matching capabilities and can be used in millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.

The company’s human stem cells have been shown to be as pluripotent as embryonic stem cells, however their creation does not involve the destruction of a viable human embryo, which effectively sidesteps the controversy and ethical dilemmas associated with the use of human embryonic stem cells. In contrast to induced pluripotent stem cells, ISCO’s stem cells do not involve manipulation of cells’ genome thereby avoiding potential safety and regulatory obstacles in clinical applications.

The company's scientists are currently focused on using its stem cells to treat severe unmet medical needs of the central nervous system (Parkinson’s disease), the liver and the eye, where cell therapy has been clinically proven but is limited due to the unavailability of safe human cells. Once the technology has been clinically validated there are an essentially unlimited number of potential applications. Because of their immune-matching ability a relatively small number of these stem cell lines could offer the potential of producing the first true stem cell bank as a means of serving populations of different immune types across the globe.

In addition to its therapeutic focus, ISCO also provides a growing revenue stream through two wholly owned subsidiaries. Lifeline Cell Technology specializes in producing primary human cells and growth media for biological research, and Lifeline Skin Care, the company manufactures and markets advanced anti-aging skincare products utilizing the company’s expertise in stem cell biology. Disclaimer

International Stem Cell Corp. Company Blog

International Stem Cell Corp. News:

International Stem Cell Corporation Announces Commencement of Enrollment of Phase I Trial of ISC-hpNSC

International Stem Cell Corporation Signed a Clinical Service Agreement With the Florey Institute of Neuroscience and Mental Health

International Stem Cell Corporation Receives Authorization to Initiate Phase I/IIa Clinical Trial of ISC-hpNSC for the Treatment of Parkinson's Disease

Lingo Media Corp. (LMDCF)

The QualityStocks Daily Newsletter would like to spotlight Lingo Media Corp. (LMDCF). Today, Lingo Media Corp. closed trading at $0.61, up 3.35%, on 18,500 volume with 4 trades. The stock’s average daily volume over the past 60 days is 4,076, and its 52-week low/high is $0.0862/$0.6745.

Lingo Media Corp. (LMDCF) (LM.V) is an EdTech company that's changing the way the world learns English through an innovative combination of proven educational techniques and accessible technology. The company provides both online and print-based solutions through its two distinct business units: ELL Technologies and Lingo Learning. Through ELL Technologies, Lingo has made considerable progress in English-learning markets throughout Latin America. Through print-based publisher Lingo Learning, the company has built a significant presence in the Chinese education market, which includes more than 300 million students.

The company's groundbreaking English programs are developed and marketed for students at every stage of development – from the classroom to the boardroom. This versatility has allowed Lingo to secure contracts and build relationships with clients in a variety of markets around the globe. In Mexico, a subsidiary of the company has partnered with a recognized university that allows it to offer its courses along with certification. In Peru, the company's subsidiary provides its groundbreaking Scholar program to a branch of the country's armed forces.

Through ELL Technologies, Lingo also markets electronic learning solutions that are suitable for pre-readers. Lingo's Kids program – which features cross-platform, multi-browser compatibility – requires no prior knowledge of the English language, allowing the company to address the entire student life cycle in blended learning environments, traditional classroom settings and the home with one cutting-edge solution. The Kids program addresses the critically underserved pre-school market, which includes roughly 181.4 million children across Asia and 30.1 million throughout Latin America and the Caribbean, according to UNESCO.

Although Lingo has traditionally leaned on its print-based offerings as a primary source of revenue, the company's recent efforts to shift into the thriving eLearning market have highlighted the immense potential of a more heavily digital approach. In the second quarter of 2015, Lingo recorded more revenue from digital products than print-based solutions for the first time in its history. With the global eLearning market set to reach $107 billion in 2015, according to a report by Global Industry Analysts, the company's performance and growing foothold in some of the world's most rapidly expanding markets place it in a favorable position. Disclaimer

Lingo Media Corp. Company Blog

Lingo Media Corp. News:

Lingo Media Selected to the 2016 TSX Venture 50 & Ranked #1 In the Diversified Industries Sector

Lingo Media to Present at the World Outlook Financial Conference 2016 on January 29th & 30th

Lingo Media Corp. (LMDCF) (LM.V) Continues to Generate Strong Profits with Q3 Net Income of $631,730

Torchlight Energy Resources, Inc. (TRCH)

The QualityStocks Daily Newsletter would like to spotlight Torchlight Energy Resources, Inc. (NASDAQ:TRCH). Today, Torchlight Energy Resources, Inc. closed trading at $0.5632, up 1.48%, on 79,905 volume with 149 trades. The stock’s average daily volume over the past 60 days is 107,745, and its 52-week low/high is $0.2201/$2.44.

Torchlight Energy Resources, Inc. (NASDAQ:TRCH) is a high growth oil and gas Exploration and Production (E&P) company primarily focused on the acquisition and development of highly profitable domestic oil fields. Leveraging a diverse portfolio, carefully selected interests, and a strong management team are pillars of Torchlight's broader success strategy.

The company maintains a diversified energy portfolio by holding interests in numerous projects in multiple established plays, and currently holds interests in Texas, Oklahoma and Kansas, where its targets are established plays such as the Wolf Penn, Eagle Ford Shale, Mississippi Limestone and Hunton Limestone trends.

Torchlight is currently moving forward on the next phase of drilling on three new wells in its Orogrande Project in West Texas, where the company owns a 47.5% working interest on 168,000 acres alongside Founders Oil and Gas, LLC. Torchlight drilled the Rich A-11 well (6,091 feet) on the Orogrande Project in March last year and subsequently executed a $50 million JV farm-out agreement with Midland, Texas-based Founders Oil and Gas, who initiated frac work on the well in November.

The Marcelina Creek Project in South Texas, with its prime access to the Austin Chalk, Buda, and Eagle Ford formations, is surrounded on all four sides by leading Eagle Ford producers. Torchlight's Johnson #4 well was recently re-entered and drilled laterally to approximately 2500 feet in the Austin Chalk Formation. With more than 20 additional drilling locations on its Marcelina Creek Asset, the project has the potential to positively impact cash flows and production sustainability.

Torchlight's executive team and board of directors are led by CEO John Brda and COO Willard McAndrew III. Combined they have over 50 years of experience in the oil and gas industry as executives, investors and consultants to the industry. Their knowledge base includes all aspects of the business including: operations, mid stream, capital formation, purchase and sale of assets, re-entries, investor relations and oil and gas consulting for public and private companies. Disclaimer

Torchlight Energy Resources, Inc. Company Blog

Torchlight Energy Resources, Inc. News:

Torchlight Energy Provides Update on the Orogrande Project

Year-End Review 2015: Torchlight Energy (NASDAQ: TRCH) by StockNewsNow

Torchlight Energy Announces Success on Its Johnson #4 Re-Entry

Immune Therapeutics, Inc. (IMUN)

The QualityStocks Daily Newsletter would like to spotlight Immune Therapeutics, Inc. (IMUN). Today, Immune Therapeutics, Inc. closed trading at $0.163, up 1.88%, on 117,701 volume with 13 trades. The stock’s average daily volume over the past 60 days is 144,164, and its 52-week low/high is $0.045/$0.36.

Immune Therapeutics, Inc. (IMUN) is a biotechnology company applying its patented immunotherapy to combat chronic, life-threatening diseases that affect persons around the world. Building on the power of the body's natural immune system, the company's pipeline of products and immunotherapy technologies are designed to enhance treatment of cancer, infections such as HIV/AIDS, chronic inflammatory diseases, and a variety of autoimmune diseases.

Immune Therapeutics' most advanced clinical programs involve immunotherapy with met-enkephalin (MENK) (sometimes referred to as opioid growth factor) and its low dose naltrexone product (LDN), internationally known as Lodonal™, both of which have been shown to stimulate immune systems even in patients with advanced cancer.

Additionally, Immune Therapeutics is pursuing additional investigations for MENK and LDN as viable treatments for autoimmune conditions such as rheumatoid arthritis and multiple sclerosis; as an adjunct in cancer patients undergoing chemotherapy, radiation treatments or surgery; and as a complement to antibiotics in the treatment of a variety of infectious diseases, including patients with HIV/AIDS, in combination with retroviral drug therapy.

Immune Therapeutics and partners AHAR Pharma and GB Pharma Holdings recently completed a bridging trial to determine the safety and efficacy of LDN in patients with HIV, and have submitted data in connection with the filing of its New Drug Application for LDN with The National Agency for Food and Drug Administration and Control, (NAFDAC) of Nigeria. Disclaimer

Immune Therapeutics, Inc. Company Blog

Immune Therapeutics, Inc. News:

Immune Therapeutics, Inc., Appoints Two New Board Members

Immune Therapeutics, Inc to Present at the SeeThruEquity & The Brewer Group 2nd Annual Innovations Investor Conference at the Ritz in South Beach on Feb. 22, 2016

SeeThruEquity Initiates Coverage on Immune Therapeutics, Inc. with a Price Target of $0.61


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters







Profitable Trader Authority

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251